Boyd Taylor's Ownership Disclosure in Avalo Therapeutics, Inc.

The filing discloses Boyd Taylor's ownership in Avalo Therapeutics, Inc. (AVTX). Boyd Taylor, the Chief Business Officer of the company, has reported no securities owned as of the period ending October 1, 2025. The filing is a Form 3, which is typically used to report initial ownership by officers, directors, and beneficial owners of more than 10% of a company's equity securities. The document was signed by Donald R. Reynolds on behalf of Boyd Taylor via a Power of Attorney. The filing provides transparency regarding the ownership structure and the roles of key executives within Avalo Therapeutics, Inc.